Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 360 of 1,261
  1. US 10947170

    Process for the preparation of deuterated ethanol from D2O

    Deuteria Beverages, LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  2. US 10947180

    Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

    VTV THERAPEUTICS LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  3. US 10945964

    Microencapsulated chitosan, methods of making and methods for the use thereof

    PRIMEX EHF · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  4. US 10939673

    Method of using mouse having a humanized cluster of differentiation 47 gene

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  5. US 10940119

    Nano-encapsulation using GRAS materials and applications thereof

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  6. US 10942183

    Methods of detecting progesterone receptor and of detecting an expression level

    Regents of the University of Minnesota · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  7. US 10941433

    Neurotransmitter transport in probiotics

    Regents of the University of Minnesota · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  8. US 10941392

    Purification of cystathionine beta-synthase

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  9. US 10941210

    Anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  10. US 10941208

    Anti-MUC16 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  11. US 10941184

    Cell-penetrating compstatin analogs and uses thereof

    Apellis Pharmaceuticals, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  12. US 10941248

    Methods for preparing functionalized polymers from polymer alcohols

    Nektar Therapeutics · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  13. US 10941200

    TREM2 cleavage modulators and uses thereof

    Ludwig-Maximilians-Universitat Munchen · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  14. US 10941135

    Nrf2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  15. US 10941159

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  16. US 10941134

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  17. US 10941143

    Imidazo [1,5-a]pyridine compounds and their use

    Alterity Therapeutics Limited · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  18. US 10940626

    Manufacturing of small film strips

    Aquestive Therapeutics, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  19. US 10940241

    Formation of stable cartilage

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  20. US 10941095

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  21. US 10940214

    Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

    The Regents of the University of California · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  22. US 10940208

    Nanoassembled complexes of nucleic acids, avidin and biotinylated compounds for use as drug carriers

    UVERA SRL · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  23. US 10941128

    Thymoquinone derivatives for treatment of cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  24. US 10940168

    Method of treating Bruch's membrane hypofunction disease

    Altregen Co., Ltd. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.